MDCX
Medicus Pharma Ltd. is a biotech and life sciences company focused on accelerating the clinical development of novel therapeutic assets, with an emphasis on oncology and non-invasive regimens. The company markets itself as advancing novel therapies for cancer, including skin cancer, through leadership with extensive experience in progressing pharmaceuticals, biologics, and combination devices toward regulatory approval and market introduction. It is NASDAQ-listed (MDCX) and references a transfer agent. Headquartered with activities tied to North American regulatory and biotech ecosystems, Medicus positions itself as a partner in advancing innovative cancer treatments.
No recent news for this company.
No recent deals for this company.